KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Amortization of Deferred Charges (2019 - 2021)

Edwards Lifesciences has reported Amortization of Deferred Charges over the past 3 years, most recently at $7.1 million for Q4 2021.

  • For Q4 2021, Amortization of Deferred Charges fell 5.33% year-over-year to $7.1 million; the TTM value through Dec 2021 reached $28.5 million, up 1.06%, while the annual FY2021 figure was $28.5 million, 1.06% up from the prior year.
  • Amortization of Deferred Charges for Q4 2021 was $7.1 million at Edwards Lifesciences, roughly flat from $7.1 million in the prior quarter.
  • Over five years, Amortization of Deferred Charges peaked at $7.5 million in Q4 2020 and troughed at $5.7 million in Q1 2019.
  • A 3-year average of $6.8 million and a median of $7.0 million in 2019 define the central range for Amortization of Deferred Charges.
  • Biggest five-year swings in Amortization of Deferred Charges: rose 17.54% in 2020 and later decreased 5.33% in 2021.
  • Year by year, Amortization of Deferred Charges stood at $6.6 million in 2019, then increased by 13.64% to $7.5 million in 2020, then decreased by 5.33% to $7.1 million in 2021.
  • Business Quant data shows Amortization of Deferred Charges for EW at $7.1 million in Q4 2021, $7.1 million in Q3 2021, and $7.0 million in Q2 2021.